Medlive Technology Past Earnings Performance
Past criteria checks 4/6
Medlive Technology has been growing earnings at an average annual rate of 41.2%, while the Healthcare Services industry saw earnings growing at 13.8% annually. Revenues have been growing at an average rate of 22.6% per year. Medlive Technology's return on equity is 5.4%, and it has net margins of 58.8%.
Key information
41.2%
Earnings growth rate
34.2%
EPS growth rate
Healthcare Services Industry Growth | 22.3% |
Revenue growth rate | 22.6% |
Return on equity | 5.4% |
Net Margin | 58.8% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital
Jul 04Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price
Apr 08Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return
Feb 20Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?
Jan 10Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price
Sep 27Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return
Jul 10Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless
May 11Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)
May 02Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 26Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital
Feb 06There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital
Oct 31Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital
Jul 14These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts
Apr 03Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?
Feb 22Revenue & Expenses Breakdown
How Medlive Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 412 | 242 | 177 | 0 |
30 Sep 23 | 384 | 216 | 167 | 0 |
30 Jun 23 | 356 | 189 | 157 | 0 |
31 Mar 23 | 335 | 153 | 154 | 0 |
31 Dec 22 | 314 | 117 | 151 | 0 |
30 Sep 22 | 300 | 83 | 143 | 0 |
30 Jun 22 | 286 | 48 | 135 | 0 |
31 Mar 22 | 285 | 44 | 131 | 0 |
31 Dec 21 | 284 | 41 | 128 | 0 |
30 Sep 21 | 270 | 55 | 109 | 0 |
30 Jun 21 | 255 | 70 | 89 | 0 |
31 Mar 21 | 234 | 78 | 71 | 0 |
31 Dec 20 | 214 | 85 | 53 | 0 |
31 Dec 19 | 122 | 31 | 37 | 0 |
31 Dec 18 | 83 | 14 | 31 | 0 |
Quality Earnings: 2192 has a high level of non-cash earnings.
Growing Profit Margin: 2192's current net profit margins (58.8%) are higher than last year (37.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2192's earnings have grown significantly by 41.2% per year over the past 5 years.
Accelerating Growth: 2192's earnings growth over the past year (106.5%) exceeds its 5-year average (41.2% per year).
Earnings vs Industry: 2192 earnings growth over the past year (106.5%) exceeded the Healthcare Services industry -3.7%.
Return on Equity
High ROE: 2192's Return on Equity (5.4%) is considered low.